These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31028100)

  • 1. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the
    Lio CJ; Shukla V; Samaniego-Castruita D; González-Avalos E; Chakraborty A; Yue X; Schatz DG; Ay F; Rao A
    Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 31028100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
    Schoeler K; Aufschnaiter A; Messner S; Derudder E; Herzog S; Villunger A; Rajewsky K; Labi V
    FEBS J; 2019 Sep; 286(18):3566-3581. PubMed ID: 31120187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
    Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
    Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.
    Morman RE; Schweickert PG; Konieczny SF; Taparowsky EJ
    Eur J Immunol; 2018 Sep; 48(9):1492-1505. PubMed ID: 29898247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility.
    Lio CW; Zhang J; González-Avalos E; Hogan PG; Chang X; Rao A
    Elife; 2016 Nov; 5():. PubMed ID: 27869616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells.
    Ise W; Kohyama M; Schraml BU; Zhang T; Schwer B; Basu U; Alt FW; Tang J; Oltz EM; Murphy TL; Murphy KM
    Nat Immunol; 2011 Jun; 12(6):536-43. PubMed ID: 21572431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally distinct roles for TET-oxidized 5-methylcytosine bases in somatic reprogramming to pluripotency.
    Caldwell BA; Liu MY; Prasasya RD; Wang T; DeNizio JE; Leu NA; Amoh NYA; Krapp C; Lan Y; Shields EJ; Bonasio R; Lengner CJ; Kohli RM; Bartolomei MS
    Mol Cell; 2021 Feb; 81(4):859-869.e8. PubMed ID: 33352108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET Enzymes and 5hmC in Adaptive and Innate Immune Systems.
    Lio CJ; Rao A
    Front Immunol; 2019; 10():210. PubMed ID: 30809228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
    Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
    Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells.
    Onodera A; González-Avalos E; Lio CJ; Georges RO; Bellacosa A; Nakayama T; Rao A
    Genome Biol; 2021 Jun; 22(1):186. PubMed ID: 34158086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.
    Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P
    Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
    Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
    Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins.
    Arioka Y; Watanabe A; Saito K; Yamada Y
    PLoS One; 2012; 7(9):e45031. PubMed ID: 23028748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET proteins and 5-methylcytosine oxidation in hematological cancers.
    Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
    Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses.
    Pone EJ; Lam T; Lou Z; Wang R; Chen Y; Liu D; Edinger AL; Xu Z; Casali P
    J Immunol; 2015 Apr; 194(7):3065-78. PubMed ID: 25740947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms that regulate the activities of TET proteins.
    Joshi K; Liu S; Breslin S J P; Zhang J
    Cell Mol Life Sci; 2022 Jun; 79(7):363. PubMed ID: 35705880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
    Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
    Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TET proteins and epigenetic modifications in cancers].
    Ciesielski P; Jóźwiak P; Krześlak A
    Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.